Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Are older antipsychotic drugs obsolete?

Literature DB >> 16763227

Are older antipsychotic drugs obsolete?

Rohan Ganguli, Martin Strassnig.

Abstract

Mesh：

Substances：
Antipsychotic Agents

Year: 2006 PMID： 16763227 PMCID： PMC1476714 DOI： 10.1136/bmj.332.7554.1346

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

10 in total

1. A meta-analysis of the efficacy of second-generation antipsychotics.

Authors: John M Davis; Nancy Chen; Ira D Glick
Journal: Arch Gen Psychiatry Date: 2003-06

2. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

Authors: Jeffrey A Lieberman; T Scott Stroup; Joseph P McEvoy; Marvin S Swartz; Robert A Rosenheck; Diana O Perkins; Richard S E Keefe; Sonia M Davis; Clarence E Davis; Barry D Lebowitz; Joanne Severe; John K Hsiao
Journal: N Engl J Med Date: 2005-09-19 Impact factor: 91.245

Review 3. Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient.

Authors: S Kapur; G Remington
Journal: Biol Psychiatry Date: 2001-12-01 Impact factor: 13.382

4. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

Authors: J Kane; G Honigfeld; J Singer; H Meltzer
Journal: Arch Gen Psychiatry Date: 1988-09

5. Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials.

Authors: S Leucht; G Pitschel-Walz; D Abraham; W Kissling
Journal: Schizophr Res Date: 1999-01-04 Impact factor: 4.939

Review 6. New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis.

Authors: Stefan Leucht; Kristian Wahlbeck; Johannes Hamann; Werner Kissling
Journal: Lancet Date: 2003-05-10 Impact factor: 79.321

7. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia.

Authors: R R Conley; C A Tamminga; J J Bartko; C Richardson; M Peszke; J Lingle; J Hegerty; R Love; C Gounaris; S Zaremba
Journal: Am J Psychiatry Date: 1998-07 Impact factor: 18.112

8. Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial.

Authors: Robert Rosenheck; Deborah Perlick; Stephen Bingham; Wen Liu-Mares; Joseph Collins; Stuart Warren; Douglas Leslie; Edward Allan; E Cabrina Campbell; Stanley Caroff; June Corwin; Lori Davis; Richard Douyon; Lawrence Dunn; Denise Evans; Ede Frecska; John Grabowski; David Graeber; Lawrence Herz; Kong Kwon; William Lawson; Felicitas Mena; Javaid Sheikh; David Smelson; Valerie Smith-Gamble
Journal: JAMA Date: 2003-11-26 Impact factor: 56.272

9. Practical treatment information for schizophrenia.

Authors: Carol A Tamminga
Journal: Am J Psychiatry Date: 2006-04 Impact factor: 19.242

10. Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic.

Authors: T Scott Stroup; Jeffrey A Lieberman; Joseph P McEvoy; Marvin S Swartz; Sonia M Davis; Robert A Rosenheck; Diana O Perkins; Richard S E Keefe; Clarence E Davis; Joanne Severe; John K Hsiao
Journal: Am J Psychiatry Date: 2006-04 Impact factor: 19.242

10 in total

5 in total

Are older antipsychotic drugs obsolete?

1. A meta-analysis of the efficacy of second-generation antipsychotics.

2. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.

Review 3. Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient.

4. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.

5. Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials.

Review 6. New generation antipsychotics versus low-potency conventional antipsychotics: a systematic review and meta-analysis.

7. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia.

8. Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial.

9. Practical treatment information for schizophrenia.

10. Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic.

1. New antipsychotic agents are much awaited.

2. Psychological and social interventions for schizophrenia.

3. Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis.

4. Diffusion of antipsychotics in the US And French markets, 1998-2008.

5. Quetiapine in the treatment of schizophrenia and related disorders.